AVTX
Avalo Therapeutics Inc.
Company Overview
| Mkt Cap | $155.59M | Price | $18.03 |
| Volume | 108.95K | Change | -0.03% |
| P/E Ratio | -4.4 | Open | $18.27 |
| Revenue | $441.0K | Prev Close | $18.04 |
| Net Income | $-35.1M | 52W Range | $3.39 - $19.41 |
| Div Yield | N/A | Target | $33.67 |
| Overall | 52 | Value | 60 |
| Quality | 31 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyAvalo Therapeutics Inc. (AVTX) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $18.03 with a market capitalization of $155.59 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows AVTX with a volume of 109K shares. The stock opened up 1.30% from yesterday's close of $18.04. Current analyst estimates project earnings of $-5.8 per share for this year, with next year targeting $-5.29.
AVTX demonstrates positive technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for AVTX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 86.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:18 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $18.03 | -0.0% | 108.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |